Viewing Study NCT01314833


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-31 @ 12:36 AM
Study NCT ID: NCT01314833
Status: COMPLETED
Last Update Posted: 2020-05-19
First Post: 2011-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module